Middle East & Africa Autoinjectors Market Size and Forecast (2021

Description

List of Tables

The Middle East and Africa Autoinjectors Market is projected to reach US$ 415.8 Million by 2034, increasing from US$ 147.7 Million in 2025. The market is expected to register a CAGR of 12.4% from 2026 to 2034.

Executive Summary and Middle East and Africa Autoinjectors Market Analysis:

The Middle East & Africa (MEA) autoinjectors market is experiencing steady expansion, primarily supported by the growing prevalence of chronic diseases, particularly diabetes and immune-mediated disorders that require injectable treatments. According to the International Diabetes Federation (IDF) Diabetes Atlas 2025, the Middle East and North Africa (MENA) region has one of the highest diabetes prevalence rates globally, estimated at approximately 17.6%. Around 85 million adults aged 20-79 were living with diabetes in the region in 2024, and the affected population is expected to continue increasing.

Across the wider MEA region, the rising burden of metabolic disorders is increasing the use of insulin, biologics, and other injectable therapies. This trend is creating greater demand for convenient and patient-friendly delivery systems that enable self-administration. Population aging in parts of North Africa and the Gulf, together with rapid urban development, changing lifestyles, and increasing obesity rates, is further contributing to the prevalence of chronic conditions requiring injectable treatment.

Healthcare systems are responding by improving access to self-injection therapies, strengthening patient education, and expanding reimbursement and training programs. At the same time, pharmaceutical and medical-device manufacturers are introducing innovative autoinjector formats featuring ergonomic designs, prefilled configurations, enhanced safety mechanisms, and optimized delivery technologies for biologic medicines and emergency treatments.

The convergence of increasing chronic disease prevalence, healthcare modernization, and technological advancement is creating favorable conditions for autoinjector adoption throughout MEA. Demand is expected to remain particularly strong across metabolic, autoimmune, and other immune-mediated conditions where convenient home-based administration can improve treatment accessibility and patient adherence.

Strategic Insights

Middle East and Africa Autoinjectors Market Segmentation Analysis:

By Type, the Middle East and Africa Autoinjectors Market is segmented into Disposable Prefilled Syringes and Reusable Prefilled Syringes. The Disposable Prefilled Syringes segment dominated the market in 2025.
By Application, the Middle East and Africa Autoinjectors Market is categorized into Cancer, Diabetes, Autoimmune Disease, Infectious Diseases, and Others. The Others segment held the largest share in 2025.
By Distribution Channel, the Middle East and Africa Autoinjectors Market is divided into Hospital Pharmacy, Retail Pharmacy, and Online Channel. The Hospital Pharmacy segment dominated the market in 2025.

Market Report Scope

Middle East and Africa Autoinjectors Market Outlook

Government-supported procurement programs represent an important source of long-term demand for autoinjectors, extending their use beyond conventional clinical applications. Countries such as the United Arab Emirates, Saudi Arabia, and Qatar are investing in emergency preparedness systems, strategic medical reserves, and advanced response infrastructure to improve their ability to address large-scale emergencies.

Government health agencies and healthcare organizations are strengthening preparedness for disaster-related incidents and other time-sensitive medical situations by maintaining supplies of essential medicines and rapid-delivery equipment. Autoinjectors can play an important role in these preparedness strategies because they provide a portable and relatively simple method for rapidly administering certain medications.

The inclusion of appropriate emergency medicines and delivery devices within national preparedness programs can generate recurring procurement requirements while simultaneously increasing awareness among healthcare professionals and the public. In countries such as the UAE and Saudi Arabia, emergency preparedness activities involve collaboration between government health authorities, defense organizations, healthcare providers, and private-sector participants.

Public-private partnerships can further facilitate the development of medical reserves, emergency response networks, and distribution systems for critical medicines and delivery technologies. These initiatives demonstrate how government planning can encourage the broader adoption of autoinjectors across routine healthcare and emergency-response environments.

As MEA governments continue to prioritize rapid access to essential treatments and decentralized healthcare delivery, incorporating autoinjectors into public health and emergency preparedness programs could provide additional opportunities for manufacturers. Such initiatives can complement growing demand from chronic disease management and help broaden the overall regional market.

Middle East and Africa Autoinjectors Market Country Insights

By country, the Middle East and Africa Autoinjectors Market is segmented into Saudi Arabia, South Africa, the United Arab Emirates, and the Rest of Middle East and Africa. The Rest of Middle East and Africa accounted for the largest market share in 2025.

Israel, Iraq, Oman, Iran, Turkey, Kuwait, and Kenya are among the important countries contributing to the market within the Rest of Middle East and Africa category. Demand across these markets is being shaped by different but interconnected healthcare trends.

Several MENA countries continue to experience high rates of diabetes. According to the IDF Diabetes Atlas 2025, Kuwait had an estimated adult diabetes prevalence of approximately 15.4%-16.4% by 2025, indicating substantial potential demand for insulin and other injectable therapies. High obesity levels in several Gulf countries are also contributing to increasing metabolic disease prevalence, while lifestyle-related risk factors continue to place pressure on healthcare systems.

Turkey and Iran have significant chronic disease burdens, including diabetes and autoimmune disorders, creating opportunities for biologic treatments delivered through autoinjector systems. Healthcare policies emphasizing patient-centered treatment and home-based administration are helping improve access to self-injection therapies and can contribute to better treatment adherence.

Israel's technologically advanced healthcare system is supporting the adoption of innovative drug-delivery technologies and digital healthcare solutions for chronic disease management. Meanwhile, countries in sub-Saharan Africa, including Kenya, are experiencing rising urbanization and greater awareness of noncommunicable diseases, gradually increasing interest in self-administered therapies.

Although healthcare infrastructure and market maturity vary considerably across MEA, improvements in patient education, healthcare accessibility, medical technology, and autoinjector design are collectively supporting regional market development.

Middle East and Africa Autoinjectors Market Company Profiles

Some of the key players operating in the market include Phillips-Medisize, Gerresheimer AG, West Pharmaceutical Services Inc, Ypsomed Holding AG, Stevanato Group SpA, Becton Dickinson and Co, Owen Mumford Ltd, Haselmeier GmbH, Nemera, and SHL Medical.

These companies are pursuing strategies including geographic expansion, product innovation, strategic collaborations, manufacturing investments, and mergers and acquisitions. Through these initiatives, market participants are seeking to introduce advanced drug-delivery solutions, improve device safety and usability, strengthen regional distribution capabilities, and expand their market share across the Middle East and Africa autoinjectors industry.

Product Code: TIPRE00043955

1. Executive Summary

1.1 Analyst Market Outlook

2. Global Autoinjectors Market Landscape

2.1 Overview
2.2 Value Chain Analysis
2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
2.4 Porter's Five Forces Analysis
2.5 PEST Analysis

3. Competitive Landscape

3.1 Company Benchmarking by Key Players
3.2 Market Share Analysis, 2025 - By Key Players
3.3 Market Concentration

4. Middle East and Africa Autoinjectors Market - Key Industry Dynamics

4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:

5. Autoinjectors Market - Middle East and Africa Analysis

5.1 Middle East and Africa Autoinjectors Market Revenue (US$ Million), 2021 - 2034
5.2 Middle East and Africa Autoinjectors Market Revenue Forecast and Analysis

6. Middle East and Africa Autoinjectors Market Revenue Analysis - by Type

6.1 Middle East and Africa Autoinjectors Market Forecast and Analysis by Type
- 6.1.1 Disposable Prefilled Syringes
  - 6.1.1.1 Overview
  - 6.1.1.2 Disposable Prefilled Syringes: Middle East and Africa Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 6.1.2 Reusable Prefilled Syringes
  - 6.1.2.1 Overview
  - 6.1.2.2 Reusable Prefilled Syringes: Middle East and Africa Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)

7. Middle East and Africa Autoinjectors Market Revenue Analysis - by Applications

7.1 Middle East and Africa Autoinjectors Market Forecast and Analysis by Applications
- 7.1.1 Cancer
  - 7.1.1.1 Overview
  - 7.1.1.2 Cancer: Middle East and Africa Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 7.1.2 Diabetes
  - 7.1.2.1 Overview
  - 7.1.2.2 Diabetes: Middle East and Africa Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 7.1.3 Autoimmune Disease
  - 7.1.3.1 Overview
  - 7.1.3.2 Autoimmune Disease: Middle East and Africa Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 7.1.4 Infectious diseases
  - 7.1.4.1 Overview
  - 7.1.4.2 Infectious diseases: Middle East and Africa Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 7.1.5 Others
  - 7.1.5.1 Overview
  - 7.1.5.2 Others: Middle East and Africa Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)

8. Middle East and Africa Autoinjectors Market Revenue Analysis - by Distribution Channel

8.1 Middle East and Africa Autoinjectors Market Forecast and Analysis by Distribution Channel
- 8.1.1 Hospital Pharmacy
  - 8.1.1.1 Overview
  - 8.1.1.2 Hospital Pharmacy: Middle East and Africa Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 8.1.2 Retail Pharmacy
  - 8.1.2.1 Overview
  - 8.1.2.2 Retail Pharmacy: Middle East and Africa Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
- 8.1.3 Online Channel
  - 8.1.3.1 Overview
  - 8.1.3.2 Online Channel: Middle East and Africa Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)

9. Middle East and Africa Autoinjectors Market - Country Analysis

9.1 Middle East and Africa
- 9.1.1 Middle East and Africa Autoinjectors Market Forecast and Analysis - by Country
  - 9.1.1.1 Saudi Arabia Market
    - 9.1.1.1.1 Saudi Arabia: Middle East and Africa Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 9.1.1.1.2 Saudi Arabia: Middle East and Africa Autoinjectors Market - By Segmentation
      - 9.1.1.1.2.1 Type
      - 9.1.1.1.2.2 Applications
      - 9.1.1.1.2.3 Distribution Channel
  - 9.1.1.2 South Africa Market
    - 9.1.1.2.1 South Africa: Middle East and Africa Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 9.1.1.2.2 South Africa: Middle East and Africa Autoinjectors Market - By Segmentation
      - 9.1.1.2.2.1 Type
      - 9.1.1.2.2.2 Applications
      - 9.1.1.2.2.3 Distribution Channel
  - 9.1.1.3 United Arab Emirates Market
    - 9.1.1.3.1 United Arab Emirates: Middle East and Africa Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 9.1.1.3.2 United Arab Emirates: Middle East and Africa Autoinjectors Market - By Segmentation
      - 9.1.1.3.2.1 Type
      - 9.1.1.3.2.2 Applications
      - 9.1.1.3.2.3 Distribution Channel
  - 9.1.1.4 Rest of Middle East and Africa Market
    - 9.1.1.4.1 Rest of Middle East and Africa: Middle East and Africa Autoinjectors Market - Revenue and Forecast, 2021 - 2034 (US$ Million)
    - 9.1.1.4.2 Rest of Middle East and Africa: Middle East and Africa Autoinjectors Market - By Segmentation
      - 9.1.1.4.2.1 Type
      - 9.1.1.4.2.2 Applications
      - 9.1.1.4.2.3 Distribution Channel

10 Autoinjectors Market Industry Landscape

11 - Key Company Profiles

11.1 Phillips-Medisize
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Gerresheimer AG
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 West Pharmaceutical Services Inc
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Ypsomed Holding AG
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Stevanato Group SpA
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Becton Dickinson and Co
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Owen Mumford Ltd
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Haselmeier GmbH
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Nemera
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 SHL Medical
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments

12. Appendix

12.1 Glossary
12.2 Research Methodology and Approach
- 12.2.1 Secondary Research
- 12.2.2 Primary Research
- 12.2.3 Market Estimation Approach
  - 12.2.3.1 Supply Side Analysis
  - 12.2.3.2 Demand Side Analysis
- 12.2.4 Research Assumptions and Limitations
- 12.2.5 Currency Conversion
12.3 About The Insight Partners
12.4 Market Intelligence Cloud